Advertisement

Diagnosis and Management of Retinoblastoma

  • Winfried E. Alberti
  • Robert H. Sagerman
Part of the Medical Radiology book series (MEDRAD)

Abstract

Although retinoblastoma accounts for only 1% of all childhood malignancies, it has been studied intensively because of its genetic features, the association with chromosomal deletions, and the known predisposition of children with retinoblastoma to develop other nonocular malignant tumors.

Keywords

Optic Nerve Retinal Detachment Unilateral Disease Retinoblastoma Patient External Beam Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abramson DH (1985) Treatment of retinoblastoma. In: Biodi FC (ed) Retinoblastoma. Churchill Livingstone, New York, pp 63–93Google Scholar
  2. Abramson DH, Ellsworth RM (1980) The surgical management of retinoblastoma. Ophthalmic Surg 11:596–598PubMedGoogle Scholar
  3. Abramson DH, Ellsworth RM, Zimmerman LE (1976) Nonocular cancer in retinoblastoma survivors. Trans Am Acad Ophthalmol Otolaryngol 81:454–457Google Scholar
  4. Abramson DH, Piro PA, Ellsworth RM et al. (1979a) Lactate dehydrogenase levels and isoenzyme patterns: measurements in the aqueous humor and serum of retinoblastoma patients. Arch Ophthalmol 97:870–872PubMedCrossRefGoogle Scholar
  5. Abramson DH, Ronner HJ, Ellsworth RM (1979b) Second tumors in nonirradiated bilateral retinoblastoma. Am J Ophthalmol 87:624–627PubMedGoogle Scholar
  6. Abramson DH, Ellsworth RM, Tretter P et al. (1981a) Simultaneous bilateral irradiation for advanced bilateral retinoblastoma. Arch Ophthalmol 99:1763–1766PubMedCrossRefGoogle Scholar
  7. Abramson DH, Ellsworth RM, Tretter P et al. (1981b) Treatment of bilateral groups I through III retinoblastoma with bilateral radiation. Arch Ophthalmol 99:1761–1762PubMedCrossRefGoogle Scholar
  8. Abramson DH, Jereb B, Ellsworth RM (1981c) External beam radiation for retinoblastoma. Bull NY Acad Med 57:787–803Google Scholar
  9. Abramson DH, Ellsworth RM, Rozakis GW (1982a) Cryotherapy for retinoblastoma. Arch Ophthalmol 100:1253–1256PubMedCrossRefGoogle Scholar
  10. Abramson DH, Marks RF, Ellsworth M et al. (1982b) The management of unilateral retinoblastoma without primary enucleation. Arch Ophthalmol 100:1249–1252PubMedCrossRefGoogle Scholar
  11. Abramson DH, Ellsworth RM, Rosenblatt M et al. (1982c) Retreatment of retinoblastoma with external beam irradiation. Arch Ophthalmol 100:1257–1260PubMedCrossRefGoogle Scholar
  12. Abramson DH, Ellsworth RM, Haik B (1983) Cobalt plaques in advanced retinoblastoma. Retina 3:12–15CrossRefGoogle Scholar
  13. Abramson DH, Ellsworth RM, Kitchin FD et al. (1984) Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced? Ophthalmology 91:1351–1355PubMedGoogle Scholar
  14. Alberti W (1991) Effects of radiation on the eye and ocular adnexa. In: Scherer E, Streffer C, Trott KR (eds) Radiopathology of organs and tissues. Springer, Springer, Berlin Heidelberg New York, pp 269–282CrossRefGoogle Scholar
  15. Alberti W, Halama J, Wannenmacher M (1987) Tumoren im Kopfbereich. Tumoren des Auges und der Orbita. In: Scherer E (ed) Strahlentherapie. Radiologische Onkologie. Springer, Berlin Heidelberg New York, pp 412–453Google Scholar
  16. Alberti W, El-Hifnawi S, Foerster MH, Bornfeld N (1990) Late effects after fractionated external beam therapy of minipig eyes in the retina and optic nerve. Int J Radiat Oncol Biol Phys 19:158–159Google Scholar
  17. Amendola BE, Lamm FR, Markoe AM et al. (1990) Radiotherapy of retinoblastoma. Cancer 66:21–26PubMedCrossRefGoogle Scholar
  18. American Cancer Society, New York (1983) Cancer facts and figures.Google Scholar
  19. Bader IL, Miller RW, Meadows AT et al. (1980) Trilateral retinoblastoma. Lancet 11:583–583Google Scholar
  20. Boniuk M, Zimmerman LE (1962) Spontaneous regression of retinoblastoma. Int Ophthalmol Clin 2:525–542CrossRefGoogle Scholar
  21. Buys RJ, Abramson DH, Ellsworth RM et al. (1983) Radiation regression patterns after cobalt plaque insertion for retinoblastoma. Arch Ophthalmol 101: 1206–1208PubMedCrossRefGoogle Scholar
  22. Carbajal UM (1959) Metastasis in retinoblastoma. Am J Ophthalmol 48:47–60PubMedGoogle Scholar
  23. Carlson EA, Letson MD, Ramsay NKC et al. (1979) Factors for improved genetic counseling for retinoblastoma based on a survey of 55 families. Am J Ophthalmol 87:449–459PubMedGoogle Scholar
  24. Cassady JR, Sagerman RH, Tretter P et al. (1969) Radiation therapy in retinoblastoma. Radiology 93:405–409PubMedGoogle Scholar
  25. Char DH (1989) Clinical ocular oncology. Churchill Livingstone, New York, pp 179–230Google Scholar
  26. Connolly MJ, Payne RH, Johnson G et al. (1983) Familial, EsD-linked, retinoblastoma with reduced penetrance and variable expressivity. Hum Genet 65:122–124PubMedCrossRefGoogle Scholar
  27. Cypress RH, Karol MH, Zidian JL et al. (1978) Larva specific antibodies in patients with visceral larva migrans. Am J Trop Med Hyg 27:492–498Google Scholar
  28. der Rinderen DJ, Koten IW, Wolterbeek R et al. (1987) Nonocular cancer in hereditary retinoblastoma survivors and relatives. Ophthalmic Paediatr Genet 8:23–25CrossRefGoogle Scholar
  29. de Sutter E, Havers W, Höpping W et al. (1987a) The prognosis of retinoblastoma in terms of globe saving treatment. A computer assisted study. Part I. Ophthalmic Paediatr Genet 8:77–84PubMedCrossRefGoogle Scholar
  30. de Sutter E, Havers W, Höpping W et al. (1987b) The prognosis of retinoblastoma in terms of survival. A computer assisted study. Part II. Ophthalmic Paediatr Genet 8:85–88PubMedCrossRefGoogle Scholar
  31. Devesa SS (1975) The incidence of retinoblastoma. Trans Am Ophthalmol Soc 67:263–265Google Scholar
  32. Donaldson SS, Egbert PR (1989) Retinoblastoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. JB Lippincott, Philadelphia, pp 555–569Google Scholar
  33. Donoso LA, Feldberg NT, Shields JA et al. (1981) Immunodiagnosis of late, recurrent retinoblastoma. Retina 1:107–112PubMedCrossRefGoogle Scholar
  34. Draper GI, Sanders BM, Kingston IE (1986) Second primary neoplasms in patients with retinoblastoma. Br J Cancer 53:661–671PubMedCrossRefGoogle Scholar
  35. Egbert PR, Donaldson SS, Moazed K et al. (1978) Visual results and ocular complications following radiotherapy for retinoblastoma. Arch Ophthalmol 96:1826–1830PubMedCrossRefGoogle Scholar
  36. Egbert PR, Fajardo LF, Donaldson SS et al. (1980) Posterior ocular abnormalities after irradiation for retinoblastoma: a histopathological study. Br J Ophthalmol 64:660–665PubMedCrossRefGoogle Scholar
  37. Ellsworth RM (1968) Treatment of retinoblastoma. Am J Ophthalmol 66:49–51PubMedGoogle Scholar
  38. Ellsworth RM (1969) The practical management of retinoblastoma. Trans Am Ophthalmol Soc 67: 462–534PubMedGoogle Scholar
  39. Ellsworth RM (1977) Retinoblastoma. Mod Probi Ophthalmol 18:94–100Google Scholar
  40. Ellsworth RM (1978) Current management of retinoblastoma. In: Jakobiec FA (ed) Ocular and adnexal tumors. Aesculapius, Birmingham, pp 128–136Google Scholar
  41. Feldberg NT, McFall R, Shields JA (1977) Aqueous humor enzyme patterns in retinoblastoma. Invest Ophthalmol Vis Sci 16:1039–1046Google Scholar
  42. Flexner S (1891) A peculiar glioma (neuro epithelioma?) of the retina. Bull Hopkins Hosp 2:115–119Google Scholar
  43. Folkmann J (1974) Tumor angiogensis factor. Cancer Res 34:2109–2113Google Scholar
  44. Forrest AW (1961) Tumors following radiation about the eye. Trans Am Acad Ophthalmol Otolaryngol 65: 694–717PubMedGoogle Scholar
  45. Freeman CR, Esseltine DL, Whitehead VM et al. (1980) Retinoblastoma: the case for radiotherapy and for adjuvant chemotherapy. Cancer 46:1913–1918PubMedCrossRefGoogle Scholar
  46. Gallie BL, Ellsworth RM, Abramson DH et al. (1982) Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer 45:513–554PubMedCrossRefGoogle Scholar
  47. Harnett AN, Hungerford IL, Lambert GD et al. (1987) Improved external beam radiotherapy for the treatment of retinoblastoma. Br J Radiol 60:753–760PubMedCrossRefGoogle Scholar
  48. Havers W, Alberti W, Messmer EP et al. (1986) Retinoblastoma. Monogr Paediatr vol 18. Karger, Basel, pp 342–358Google Scholar
  49. Haye C, Schlienger P, Calle R et al. (1986) Traitement conservateur des tumeurs de la rétine a l’Institut Curie. Bull Cancer (Paris) 73:260–270Google Scholar
  50. Heinrich T (1989) Das Metastasierungsrisiko beim Retinoblastom. Eine Prognoseklassifikation auf dem Boden einer multivariaten Analyse potentieller Einflußfaktoren. Dissertation, University of EssenGoogle Scholar
  51. Hilgartner HL (1903) Report of a case of double glioma treated by x-rays. Tex Med J 18:322Google Scholar
  52. Hille P (1989) Spätergebnisse der Strahlentherapie bilateraler Retinoblastome unter besonderer Berücksichtigung maligner Zweitneoplasien. Essen 1940–1973. Dissertation, University of EssenGoogle Scholar
  53. Hopping W (1983) The new Essen prognosis classification for conservative sightsaving treatment of retinoblastoma. In: Lommatzsch PK, Biodi FC (eds) Intraocular tumors. Akademie, Berlin, pp 497–505Google Scholar
  54. Höpping W, Bunke-Schmidt A (1985) Light coagulation and cryotherapy. In: Biodi FC (ed) Retinoblastoma. Churchill Livingstone, New York, pp 95–110Google Scholar
  55. Höpping W, Meyer-Schwickerath G (1964) Light coagulation treatment in retinoblastoma. In: Boniuk M (ed) Ocular and adnexal tumors. New and controversial aspects. C.V. Mosby, St. Louis, pp 192–196Google Scholar
  56. Hopping W, Havers W, Alberti W et al. (1985a) Klinische Gesichtspunkte des Retinoblastoms. In: Hammerstein W, Lisch W (eds) Ophthalmologische Genetik. Ferdinand Enke, Stuttgart, pp 324–338Google Scholar
  57. Höpping W, Alberti W, Havers W et al. (1985b) Das Retinoblastom. In: Lund OE, Waubke TN (eds) Die Augenerkrankungen im Kindesalter. Enke, Stuttgart, pp 199–217Google Scholar
  58. Howard GM (1966) Ocular effects of radiation and photocoagulation. Arch Ophthalmol 76:7–10PubMedCrossRefGoogle Scholar
  59. Howard RO (1982) Chromosome errors in retinoblastoma. Birth Defects 18:703–727PubMedGoogle Scholar
  60. Howarth C, Meyer D, Hustu O et al. (1980) Stage-related combined modality treatment of retinoblastoma. Cancer 45:851–858PubMedCrossRefGoogle Scholar
  61. Jakobiec FA, Tso MOM, Zimmerman LE et al. (1977) Retinoblastoma and intracranial malignancy. Cancer 39:2048–2058PubMedCrossRefGoogle Scholar
  62. Jensen RD, Miller RW (1971) Retinoblastoma: epidemiology characteristics. N Engl J Med 285: 307–311PubMedCrossRefGoogle Scholar
  63. Judisch GF, Apple DI, Fratkin ID (1980) A survivor 12 years after treatment for metastatic disease. Arch Ophthalmol 98:711–713PubMedCrossRefGoogle Scholar
  64. Khodadoust AA, Roozitalab HM, Smith RE et al. (1977) Spontaneous regression of retinoblastoma. Surv Ophthalmol 21:468–478CrossRefGoogle Scholar
  65. Kitchin FD (1976) Genetics of retinoblastoma. In: Reese AB (ed) Tumors in the eye. Harper and Row, Hagerstown, pp 125–132Google Scholar
  66. Knieper C (1911) Ein Fall von doppelseitigem Glioma retinae mit Enucleation des einen und nunmehr fast 11-jähriger Atrophie des anderen Auges. A.v. Graefes Arch Klin Ophthalmol 78:310–330Google Scholar
  67. Knudson JR (1971) Mutation and cancer: statistically study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823PubMedCrossRefGoogle Scholar
  68. Koten JW, der Kinderen DJ, Otter WD (1988) Editorial reply. N Engl J Med 318:581–582PubMedCrossRefGoogle Scholar
  69. Kupfer C (1953) Retinoblastoma treated by intravenous nitrogen mustard. Am J Ophthalmol 36:1721–1724PubMedGoogle Scholar
  70. Kyritsis AP, Tsokos M, Triche TI et al. (1984) Retinoblastoma-origin from a primitive neuroectodermal cell? Nature 307:471–473PubMedCrossRefGoogle Scholar
  71. Lennox EL, Draper GJ, Sanders BM (1975) Retinoblastoma: a study of natural history and prognosis of 268 cases. Br Med J 3:731–734PubMedCrossRefGoogle Scholar
  72. Lincoff H, McLean J, Long R (1967) The cryosurgical treatment of intraocular tumors. Am J Ophthalmol 63:389–399PubMedGoogle Scholar
  73. Lommatzsch PK (1978) Experience with beta-irradiation (106Ru/106Rh) of patients suffering from retinoblastoma (report on 33 patients). Jpn J Ophthalmol 22:424–430Google Scholar
  74. Lommatzsch PK (1989) Intraokulare Tumoren. Enke, StuttgartGoogle Scholar
  75. Lueder GT, Judisch GF, O’Gorman TW (1986) Second nonocular tumors in survivors of heritable retinoblastoma. Arch Ophthalmol 104:372–3PubMedCrossRefGoogle Scholar
  76. Macklin MT (1960) A study of retinoblastoma in Ohio. Am J Hum Genet 12:1–43PubMedGoogle Scholar
  77. Margo CE, Hidayat A, Kopelman I et al. (1983) Retinocytoma: a benign variant of retinoblastoma. Arch Ophthalmol 101:1519–1531PubMedCrossRefGoogle Scholar
  78. McFaul PA, Bedford MA (1970) Ocular complications after therapeutic irradiation. Br J Ophthalmol 54: 237–247CrossRefGoogle Scholar
  79. McKay CI, Abramson DH, Ellsworth RM (1984) Metastatic patterns of retinoblastoma. Arch Ophthalmol 102:391–396CrossRefGoogle Scholar
  80. Meadows AT (1988) Risk factors for second malignant neoplasms. Report from the Late Effects Study Group. Bull Cancer (Paris) 75:125–130Google Scholar
  81. Meadows AT, Strong LC, Li FP et al. (1980) Bone sarcoma as a second malignant neoplasm in children: influence of radiation and genetic predisposition. Cancer 46:2603–2606PubMedCrossRefGoogle Scholar
  82. Merriam GR (1950) Retinoblastoma: analysis of 17 autopsies. Arch Ophthalmol 44:71–108CrossRefGoogle Scholar
  83. Messmer EP (1989) Die Histopathologic des Retinoblastoms unter besonderer BerücksichtigungGoogle Scholar
  84. Messmer EP, Sauerwein W, Heinrich T et al. (1990) New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma. Graefes Arch Clin Exp Ophthalmol 228:426–431PubMedCrossRefGoogle Scholar
  85. Meyer-Schwickerath G (1961) The preservation of vision by treatment of intraocular tumors with light coagulation. Arch Ophthalmol 66:458–466PubMedCrossRefGoogle Scholar
  86. Meyer-Schwickerath G, Helferich E (1958) Zur Therapie des Retinoblastoms. Klin Monatsbl Augenheilkd 132: 806–817Google Scholar
  87. Motegi T, Kaga M, Yanagawa Y et al. (1983) A recognizable pattern of the midface of retinoblastoma patients with interstitial deletion of 13q. Hum Genet 64: 160–162PubMedCrossRefGoogle Scholar
  88. Pollard ZF, Jarrett WH, Hagler WS et al. (1979) ELISA for diagnosis of ocular toxocariasis. Am J Ophthalmol 86:743–749Google Scholar
  89. Pratt CB (1972) Management of malignant solid tumors in children. Pediatr Clin North Am 19:1141–1155PubMedGoogle Scholar
  90. Pratt CB, Meyer D, Chenaille P et al. (1989) The use of bone marrow aspirations and lumbar punctures at the time of diagnosis of retinoblastoma. J Clin Oncol 7:140–143PubMedGoogle Scholar
  91. Redler LD, Ellsworth RM (1973) Prognostic importance of choroidal invasion in retinoblastoma. Arch Ophthalmol 90:294–296PubMedCrossRefGoogle Scholar
  92. Reese AB (1976) Retinoblastoma and other neuroectodermal tumors of the retina. In: Haverstraw MD (ed) Tumors of the eye, 3rd edn. Harper & Row, New York, pp 89–133Google Scholar
  93. Reese AB, Ellsworth RM (1963) The evaluation and current concept of retinoblastoma therapy. Am Acad Ophthalmol Otolaryngol 67:164–172Google Scholar
  94. Reese AB, Merriam GR, Martin HE (1949) Treatment of bilateral retinoblastoma by irradiation and surgery. Am J Ophthalmol 32:175–190PubMedGoogle Scholar
  95. Reese AB, Hyman G, Merriam GR et al. (1955) Treatment of retinoblastoma by radiation and triethylene melamine. Arch Ophthalmol 53:505–513CrossRefGoogle Scholar
  96. Roarty ID, McLean IW, Zimmerman LE (1988) Incidence of second neoplasms in patients and their parents. Cancer 95:1583–1587Google Scholar
  97. Rootman J, Hofbauer J, Ellsworth RM et al. (1976) Invasion of the optic nerve by retinoblastoma: a clinicopathologic study. Can J Ophthalmol 11:106–114PubMedGoogle Scholar
  98. Rosengren BH, Tengroth B (1963) A modified cobalt 60 applicator for the treatment of retinoblastoma. Acta Radiol Oncol Radiat Phys Biol 1:310–314Google Scholar
  99. Rubin CM, Robinson LL, Camaron JD et al. (1985) Intraocular retinoblastoma group V: an analysis of prognostic factors. J Clin Oncol 3:680–685PubMedGoogle Scholar
  100. Sagerman RH, Cassady JR, Tretter P et al. (1969) Radiation induced neoplasia following external beam therapy for children with retinoblastoma. AJR 105: 529–535Google Scholar
  101. Schimke RN, Kowman IT, Cowan GAB (1974) Retinoblastoma and osteogenic sarcoma in siblings. Cancer 34:2077–2079PubMedCrossRefGoogle Scholar
  102. Schipper J (1980) Retinoblastoma. A medical and experimental study. Thesis, UtrechtGoogle Scholar
  103. Schipper J (1983) An accurate and simple method for megavoltage radiation therapy of retinoblastoma. Radiother Oncol 1:31–41PubMedCrossRefGoogle Scholar
  104. Schipper J, Alberti W (1985) Second nonocular cancer in retinoblastoma survivors. Letter to the editor. Ophthalmology 92:60A–62APubMedGoogle Scholar
  105. Schipper J, Tan KEWP, van Peperzeel A (1985) Treatment of retinoblastoma by precision megavoltage radiation therapy. Radiother Oncol 3:117–132PubMedCrossRefGoogle Scholar
  106. Schlienger P, Calle R, Haye C et al. (1985) Sarcomes osseux et tumeurs malignes de la retine. Bull Cancer (Paris) 72:16–24Google Scholar
  107. Shah IC, Arlen M, Miller T (1974) Osteogenic sarcoma developing after radiotherapy for retinoblastoma. Am Surg 40:485–490PubMedGoogle Scholar
  108. Shields JA, Augsburger JJ (1981) Current approaches to the diagnosis and management of retinoblastoma. Surv Ophthalmol 25:347–353PubMedCrossRefGoogle Scholar
  109. Smith LM, Donaldson SS, Egbert PR et al. (1989) Aggressive management of second primary tumors in survivors of hereditary retinoblastoma. Int J Radiat Oncol Biol Phys 17:499–505PubMedCrossRefGoogle Scholar
  110. Soloway HB (1966) Radiation-induced neoplasms following curative therapy of retinoblastoma. J Am Soc Cancer 19:1984–1988Google Scholar
  111. Sparkes RS, Murphree AL, Lingua RW et al. (1983) Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase D. Science 219: 971–973PubMedCrossRefGoogle Scholar
  112. Stallard HB (1933) Radient energy as (a) a pathogenic (b) a therapeutic agent in ophthalmic disorders. Br J Ophthalmol, Monograph Supplement 6Google Scholar
  113. Stallard HB (1955) Multiple islands of retinoblastoma. Br J Ophthalmol 39:241–243PubMedCrossRefGoogle Scholar
  114. Stallard HB (1966) The treatment of retinoblastoma. Ophthalmologica 151:214–230PubMedCrossRefGoogle Scholar
  115. Stallard HB (1968) The treatment of retinoblastoma. Mod Probl Ophthalmol 7:149–173Google Scholar
  116. Stannard C, Lipper S, Sealy R et al. (1979) Retinoblastoma: correlation of invasion of the optic nerve and choroid with prognosis and metastases. Br J Ophthalmol 63:560–570PubMedCrossRefGoogle Scholar
  117. Stannard C, Sealy R, Shackleton D et al. (1987) The use of iodine-125 plaques in the treatment of retinoblastoma. Ophthalmic Paediatr Genet 8:89–93PubMedCrossRefGoogle Scholar
  118. Verhoeff FH (1922) Primary intraneural tumors (gliomas) of the optic nerve. Arch Ophthalmol 51:120Google Scholar
  119. Virchow R (1864) Die krankhaften Geschwülste, vol 2. Hirschwald, BerlinGoogle Scholar
  120. Vogel F (1979) Genetics of retinoblastoma. Hum Genet 52:1–54PubMedCrossRefGoogle Scholar
  121. Weiss DR, Cassady JR, Petersen R (1975) Retinoblastoma: a modification in radiation therapy technique. Radiology 114:705–708PubMedGoogle Scholar
  122. Wintersteiner H (1894) Über Bau, Wachstum und Genese des Glioma Retinae. Wien Klin Wochenschr 7:493Google Scholar
  123. Winther J, Olsen JH, de Nully Brown P (1988) Risk of nonocular cancer among retinoblastoma patients and their parents. Cancer 62:1458–1462PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • Winfried E. Alberti
    • 1
  • Robert H. Sagerman
    • 2
  1. 1.Clinic for Radiation Therapy and Nuclear MedicineAlfried Krupp HospitalEssen 1Germany
  2. 2.Radiation Oncology Division, Health Science CenterState University of New YorkSyracuseUSA

Personalised recommendations